The US Food and Drug Administration (FDA) has unveiled a new action plan to ensure the safety of medical devices and patient protection while also driving innovation.
Titled ‘Medical Device Safety Action Plan: Protecting Patients, Promoting Public Health’, the proposal seeks better cybersecurity for devices with new and advanced technologies.
In addition, the agency will work towards the optimisation and implementation of post-market mitigations, and a combination of pre- and post-market activities to track the total product life cycle (TPLC) of devices.
